MedPath

The effect of probiotics on indirect bilirubin levels

Phase 3
Recruiting
Conditions
Jaundice in babies.
Neonatal jaundice, unspecified
P59.9
Registration Number
IRCT20180311039048N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

1- Infants suffering from neonatal jaundice who have referred to Mousavi Zanjan Hospital and are indicated for hospitalization.
2- Babies for whom no fetal anomalies were mentioned before birth.
3- Babies whose jaundice is not pathological.

Exclusion Criteria

1- Babies whose jaundice started on the first day
2- Babies whose jaundice is related to biliary atresia
3- The baby's family is not satisfied.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of indirect bilirubin that led to hospitalization. Timepoint: The first day of hospitalization, the second day of hospitalization, the third day of hospitalization. Method of measurement: By laboratory kits through blood sampling.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath